期刊文献+

急性脑梗死静脉溶栓后早期脑出血转化的相关因素分析 被引量:14

Analysis of factors that related to the early cerebral hemorrhagic transformation after intravenous thrombolysis in patients with acute cerebral infarction
下载PDF
导出
摘要 目的:探讨影响急性脑梗死静脉溶栓早期脑出血转化的相关因素。方法:回顾性分析98例行静脉溶栓的急性脑梗死患者的临床资料,以溶栓后24 h及病情加重时头颅CT或MRI判断有无脑出血转化,比较脑出血转化组和无脑出血转化组患者的年龄、性别、高血压病史、糖尿病史、房颤、吸烟、发病至溶栓的间隔时间(<3 h或3~6 h)、溶栓前后的收缩压和舒张压、溶栓前血糖、溶栓前纤维蛋白原、溶栓前NIHSS评分、溶栓药物类型(rt-PA或UK)。使用Logistic回归分析以上与溶栓早期脑出血转化有关的因素。结果:本组急性脑梗死患者共98例,经溶栓治疗后发生脑出血转化(CHT)15例(15/98)。。CHT组心房颤动患者比率高于无CHT组(40%vs 12%,P=0.015),CHT组溶栓前NIHSS评分高于无CHT组(14 vs 10,P=0.025),CHT组溶栓后收缩压高于无CHT组(161±23 vs 139±20,P=0.003)。Logistic回归分析显示溶栓前NIHSS评分(OR=1.181,95%CI:1.037~1.346,P=0.012)、溶栓后收缩压(OR=1.079,95%CI:1.031~1.128,P=0.001)与溶栓后早期脑出血转化独立相关。结论:影响急性脑梗死静脉溶栓早期脑出血转化的相关因素有溶栓前NIHSS评分和溶栓后收缩压。 Objective:To investigate the factors that associated with the early cerebral hemorrhagic transformation(CHT) after intravenous thrombolysis in patients with acute cerebral infarction. Methods : To analyze retrospectively the data of all 98 patients who had received intravenous thrombolytic therapy. CHT was assessed by CT or MRI performed at 24 h after treatment or sympotamatic deterioration within 24 h. Age, sex, history of hypertention and diabetes mellitus, smoking, atrial fibrillation, time from onset to treatment, systolic and diastolic blood pressure before and after treatment, baseline serum glucose and serum fibrinogen, NIHSS scores before treatment and type of thrombolytic medications were compared between patients with and without CHT. Logistic regression analysis was used to determine the independent factors associated to the CHT. Results:Fifteen patients had CHT. As compared to patients without CHT, patients with CHT had higher proportion of atrial fibrillation (40% vs 12% ,P = 0. 015 ) and higher NIHSS scores before treatment (14 vs 10 ,P = 0. 025 ), as well as higher level of systolic blood pressure after treatment (161 ± 23 vs 139 ± 20 ,P = 0. 003 ). Multiple logistic regression analysis showed that NIHSS scores before treatment( OR = 1. 181,95% CI: 1. 037 - 1. 346,P = 0. 012) and systolic blood pressure after treatment ( OR = 1. 079,95 % CI: 1.031 - 1.128, P = O. 001 ) were independent factors that associated with the CHT. Conclusion:NIHSS scores before treatment and systolic blood pressure after treatment are factors that associated with the early CHT after intravenous thrombolysis in patients with acute cerebral infarction.
出处 《赣南医学院学报》 2013年第2期199-202,共4页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 急性脑梗死 溶栓治疗 脑出血 Acute cerebral infarction Thrombolytic therapy Cerebral hemorrhage
  • 相关文献

参考文献12

  • 1Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) : an observational study [ J ]. Lancet,2007, 369:275 - 282.
  • 2Dzialowski I, Pexman JH, Barber PA, et al. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry [ J ]. Stroke, 2007,38 (1) :75 -79.
  • 3Kimura K, Iguchi Y, Shibazaki K, et al. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery [ J ]. J Neurol Sci, 2008, 272 : 136 - 142.
  • 4Butcher K, Christensen S, Parsons M, et al. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation [ J]. Stroke,2010,41 ( 1 ) : 72 - 77.
  • 5Perini F, De Boni A, Marcon M,et al. Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke[ J]. J Neurol Sci ,2010,297 ( 1 -2) :52-54..
  • 6Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR) [ J ]. Stroke, 2009,40 ( 7 ) : 2442 - 2449.
  • 7Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Muhicenter rt-PA Stroke Survey [ J ]. Circulation, 2002,105 ( 14 ) : 1679 - 1685.
  • 8Derex L, Hermier M, Adeleine P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator [ J ]. J Neurol Neurosurg Psychiatry, 2005,76 ( 1 ) : 70 - 75.
  • 9Wahlgren N ,Ahmed N,Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) [ J ]. Stroke, 2008,39(12) :3316 - 3322.
  • 10England TJ, Bath PM, Sare GM, et al. Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype:assessment from the Tinzaparin in Acute Ischaemic Stroke Trial [ J ]. Stroke, 2010,41 (12) :2834 - 2839.

二级参考文献8

  • 1Katzan I L, Furlan A J, Lloyd L E, et al. Use of tissue - type plasminogen activator for acute ischemic stroke: the Cleveland area experience[J]. JAMA, 2000,283 :1151 - 1158.
  • 2The NINDS rt -PA stroke study group. Intracerebral hemorrhage after intravenous t- PA therapy for ischemic stroke[J].Stroke, 1997,28:2109 - 2118.
  • 3Larrue V,von Kummer R,del Zoppo G,et al. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European cooperative acute stroke study[J]. Stroke, 1997,28: 957 - 960.
  • 4Branston N M,Bell B A,Hunstock A. Time and flow as factors in the formation of postischemic edema in primate cortex. In:Cervos - Navarro J, Ferszt R, eds. Advances in neurology [M].Vol 28. Brain Edema. Raven Press Publishers, 1980. 291 - 298.
  • 5Lodder J, Krijne - Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy:cardiac embolic cause and the relationship to the cause of death[J]. Stroke,1986,17:626 - 629.
  • 6Albers G W,Bates V E,Clark W E,et al. Intravenous tissue -type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study[J]. JAMA,2000,283:1145 - 1150.
  • 7贺茂林,陈清棠.机遇和挑战:面向21世纪的急性脑梗死溶栓治疗[J].中国危重病急救医学,2000,12(5):259-260. 被引量:30
  • 8国家"九五"攻关课题协作组.急性脑梗死六小时以内的静脉溶栓治疗[J].中华神经科杂志,2002,35(4):210-213. 被引量:372

共引文献25

同被引文献102

引证文献14

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部